brand names of glp-1 agonists GLP-1 medications mentioned by the WHO. The World Health Organization released its first global guideline on using GLP-1 GLP-1 Medications: What You Need

A common feature is immune dysregulation, where, in Graves disease, autoantibodies stimulating the thyroid to produce an excessive amount of hormone and, in Hashimotos thyroiditis, the thyroid gland suffers autoimmune destruction (Bari et al

Dynamic control of beta1 integrin adhesion by the plexinD1-sema3E axis

One idea is to enhance the activity of amino acid metabolism of CAR-T cells by adding cytokines that promote the expression of transporters related to amino acid metabolism, such as SLC1A5, SLC3A2 and SLC7A5, or directly importing transcripts encoding these AATs into T cells

686(2): 12939 Schmidt-Sommerfeld E, Penn D